参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/08/10 | 1,020 | 1,043 | 1,014 | 1,043 | +19 | +1.9% | 1,285,900 |
2022/08/09 | 1,043 | 1,050 | 1,024 | 1,024 | -14 | -1.3% | 1,202,800 |
2022/08/08 | 1,062 | 1,063 | 1,035 | 1,038 | -20 | -1.9% | 1,740,500 |
2022/08/05 | 1,058 | 1,074 | 1,048 | 1,058 | -4 | -0.4% | 1,751,200 |
2022/08/04 | 1,070 | 1,070 | 1,048 | 1,062 | +13 | +1.2% | 1,916,200 |
2022/08/03 | 1,051 | 1,054 | 1,039 | 1,049 | +7 | +0.7% | 1,771,500 |
2022/08/02 | 1,070 | 1,073 | 1,038 | 1,042 | -39 | -3.6% | 1,910,500 |
2022/08/01 | 1,075 | 1,084 | 1,072 | 1,081 | +4 | +0.4% | 1,140,800 |
2022/07/29 | 1,096 | 1,096 | 1,071 | 1,077 | -11 | -1% | 1,674,900 |
2022/07/28 | 1,102 | 1,102 | 1,081 | 1,088 | -12 | -1.1% | 1,848,500 |
2022/07/27 | 1,100 | 1,103 | 1,093 | 1,100 | +6 | +0.5% | 1,257,600 |
2022/07/26 | 1,103 | 1,104 | 1,089 | 1,094 | -9 | -0.8% | 1,211,500 |
2022/07/25 | 1,103 | 1,107 | 1,098 | 1,103 | -1 | -0.1% | 985,100 |
2022/07/22 | 1,105 | 1,118 | 1,104 | 1,104 | -5 | -0.5% | 1,287,300 |
2022/07/21 | 1,082 | 1,109 | 1,082 | 1,109 | +7 | +0.6% | 1,176,600 |
2022/07/20 | 1,092 | 1,103 | 1,081 | 1,102 | +25 | +2.3% | 1,238,900 |
2022/07/19 | 1,089 | 1,090 | 1,067 | 1,077 | -16 | -1.5% | 1,503,000 |
2022/07/15 | 1,089 | 1,098 | 1,077 | 1,093 | +13 | +1.2% | 1,369,600 |
2022/07/14 | 1,074 | 1,083 | 1,071 | 1,080 | -1 | -0.1% | 1,134,900 |
2022/07/13 | 1,092 | 1,093 | 1,074 | 1,081 | -5 | -0.5% | 1,601,800 |
2022/07/12 | 1,097 | 1,100 | 1,082 | 1,086 | -18 | -1.6% | 1,519,700 |
2022/07/11 | 1,104 | 1,105 | 1,088 | 1,104 | +26 | +2.4% | 1,914,500 |
2022/07/08 | 1,087 | 1,091 | 1,067 | 1,078 | -16 | -1.5% | 2,749,400 |
2022/07/07 | 1,086 | 1,096 | 1,074 | 1,094 | +13 | +1.2% | 1,706,600 |
2022/07/06 | 1,053 | 1,082 | 1,051 | 1,081 | +28 | +2.7% | 2,008,500 |
2022/07/05 | 1,061 | 1,061 | 1,046 | 1,053 | -4 | -0.4% | 916,900 |
2022/07/04 | 1,074 | 1,075 | 1,049 | 1,057 | +2 | +0.2% | 958,400 |
2022/07/01 | 1,064 | 1,083 | 1,052 | 1,055 | -9 | -0.8% | 1,571,600 |
2022/06/30 | 1,060 | 1,077 | 1,058 | 1,064 | -1 | -0.1% | 2,098,700 |
2022/06/29 | 1,037 | 1,066 | 1,036 | 1,065 | +7 | +0.7% | 1,888,800 |
2022/06/28 | 1,045 | 1,058 | 1,036 | 1,058 | +10 | +1% | 1,930,900 |
2022/06/27 | 1,045 | 1,050 | 1,035 | 1,048 | +6 | +0.6% | 1,475,100 |
2022/06/24 | 1,039 | 1,043 | 1,024 | 1,042 | +8 | +0.8% | 1,923,900 |
2022/06/23 | 1,017 | 1,034 | 1,017 | 1,034 | +23 | +2.3% | 3,211,700 |
2022/06/22 | 1,000 | 1,018 | 998 | 1,011 | +12 | +1.2% | 3,081,700 |
2022/06/21 | 1,005 | 1,010 | 993 | 999 | +6 | +0.6% | 2,162,900 |
2022/06/20 | 996 | 998 | 983 | 993 | -3 | -0.3% | 2,023,300 |
2022/06/17 | 970 | 996 | 968 | 996 | +11 | +1.1% | 4,162,400 |
2022/06/16 | 991 | 994 | 981 | 985 | +7 | +0.7% | 2,720,600 |
2022/06/15 | 985 | 988 | 968 | 978 | -17 | -1.7% | 4,230,600 |
2022/06/14 | 984 | 999 | 982 | 995 | -13 | -1.3% | 2,937,100 |
2022/06/13 | 998 | 1,010 | 993 | 1,008 | ±0 | ±0% | 1,972,200 |
2022/06/10 | 1,005 | 1,012 | 1,002 | 1,008 | -13 | -1.3% | 2,222,100 |
2022/06/09 | 1,010 | 1,033 | 1,008 | 1,021 | +2 | +0.2% | 2,774,900 |
2022/06/08 | 999 | 1,026 | 998 | 1,019 | +24 | +2.4% | 3,639,600 |
2022/06/07 | 997 | 1,005 | 990 | 995 | -9 | -0.9% | 4,267,400 |
2022/06/06 | 1,001 | 1,014 | 1,000 | 1,004 | -2 | -0.2% | 1,926,200 |
2022/06/03 | 1,007 | 1,024 | 1,002 | 1,006 | -5 | -0.5% | 3,029,200 |
2022/06/02 | 1,021 | 1,023 | 1,005 | 1,011 | -40 | -3.8% | 3,746,200 |
2022/06/01 | 1,038 | 1,069 | 1,037 | 1,051 | +9 | +0.9% | 3,190,300 |
651~
700
件表示中 / 3675件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 140,200円 | 0.0% | +50.6% | 2.57% | 14.73倍 | 1.66倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 168,200円 | -3.5% | -50.2% | 4.76% | 13.63倍 | 1.01倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 216,000円 | +18.2% | +4.2% | 1.67% | 15.16倍 | 1.93倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
久光薬 | 391,800円 | +8.7% | +17.1% | 2.30% | 13.94倍 | 1.05倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 405,700円 | +20.9% | +87.3% | 3.35% | 9.06倍 | 1.05倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム